Affimednv Stock Exchange News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affimednv stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affimednv Stock Exchange Today - Breaking & Trending Today

Affimed Announces Acceptance of Abstracts at the 17th International Conference on Malignant Lymphoma (17-ICML)

A pre-clinical data set of AFM13 in combination with Artiva Biotherapeutics Inc.’s allogeneic NK cell AB-101 shows that AFM13 enhances the cytotoxic activity of AB-101 against tumor cells and. | June 9, 2023 ....

United States , New York , Baden Wüberg , Soult Ukpyolsi , South Korea , Artiva Allo , Alexander Fudukidis , Arndt Schottelius , Seog Kim , Jens Pahl , Mary Beth Sandin , Artiva Biotherapeutics Inc , International Conference On Malignant Lymphoma , Globenewswire Inc , University Of Texas Md Anderson Cancer Center , Drug Administration , Samsung Medical Center , Malignant Lymphoma , Chief Scientific Officer , Presentation Time , Abstract Book Code , Medical Center , Cancer Center , Affimednv Stock Exchange , Press Release , Ells Afmd Nl0010872420 ,

Transcript : Affimed N.V. - Special Call

Presentation Operator MessageOperator Good day, everyone, and welcome to Affimed s AFM24 Update Call. [Operator Instructions]I would now like to introduce your host for day s call, Alex Fudukidis,. | June 4, 2023 ....

Alex Fudukidis , Investor Relations , Affimednv Stock Exchange , Press Release , Lex Afmd Nl0010872420 ,

Affimed Announces Annual General Meeting of Shareholders

HEIDELBERG, Germany, May 22, 2023 Affimed N.V. , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its 2023. | May 22, 2023 ....

New York , United States , Baden Wüberg , Noord Holland , Prins Hendrikkade , Alexander Fudukidis , Globenewswire Inc , General Meeting , Amsterdam Barbizon Palace , Annual Meeting , Investor Contact , Affimednv Stock Exchange , Press Release , Ts Afmd Nl0010872420 ,

Affimed to Report First Quarter 2023 Financial Results & Corporate Update on May 23, 2023

HEIDELBERG, Germany, May 16, 2023 Affimed N.V. , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will. | May 16, 2023 ....

New York , United States , Baden Wüberg , Alexander Fudukidis , Globenewswire Inc , Affimednv Stock Exchange , Press Release , T Afmd Nl0010872420 ,

Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association

A post-hoc subgroup analysis from the AFM13 REDIRECT study in patients with relapsed/refractory peripheral T cell lymphoma is accepted as a poster presentationA trial in progress abstract of the. | May 11, 2023 ....

Baden Wüberg , United States , New York , Mary Beth Sandin , Jake Shortt , Alexander Fudukidis , University Of Texas Md Anderson Cancer Center , European Hematology Association , Post Hoc Subgroup Analysis , Abstract Code , Engaging Innate Immunity , Escalation Study , Assess Safety , Positive Acute Myeloid Leukemia , Innate Cell Engager , Redirected Optimized Cell Killing , Cancer Center , Affimednv Stock Exchange , Press Release , F Afmd Nl0010872420 ,